No Heavy Drinking Days and Percentage of Days Abstinent in a Randomized Trial of Adjunctive Ketamine for Alcohol Use Disorder: Secondary Analysis of the KARE Trial
Morgan, C. J.; Nutt, D. J.
Show abstract
In the KARE trial, 96 adults with severe alcohol use disorder, abstinent following detoxification, were randomised in a 2x2 factorial design to 3 weekly infusions of ketamine (0.8 mg/kg) or saline, each combined with mindfulness-based psychological support (PS) or alcohol psychoeducation (PE). We re-expressed the trial data on endpoints acceptable to regulators and compared the most and least intensive arms. Across pooled weeks 17-24, ketamine plus PS gave 78.5% versus 57.8% days abstinent (difference, 20.7 percentage points; P = .032); adjusted for baseline, the difference at weeks 21-24 was 26.9 percentage points (P = .011). At weeks 21-24, 50.0% versus 26.1% had no heavy drinking days (P = .127). Relative reductions in heavy drinking days were 55% in KARE, against 25%, -17%, 46% and 35% reported for naltrexone, exenatide, semaglutide and pemvidutide. These post hoc differences, measured 4 to 6 months after a 4 week course ended, are of magnitude similar to agents requiring continuous administration.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Association of Topiramate Prescribed for any Indication with Reduced Alcohol Consumption in Electronic Health Record Data 94%
- Age-based differences in quantity and frequency of consumption when screening for harmful alcohol use 93%
- Impact of health warning labels and calorie labels on selection and purchasing of alcoholic and non-alcoholic drinks: a randomised controlled trial 93%
Similar papers in this journal
Similar papers in this journal
- Agreement between DSM-IV and DSM-5 measures of substance use disorders in a sample of adult substance users 92%
- Changes in injecting versus smoking heroin, fentanyl, and methamphetamine among people who inject drugs in San Diego, California, 2020 to 2023 92%
- Medication Improves Age Disparities in Six-Month Treatment Retention for Opioid Use Disorder 92%
Similar papers in this journal
- Specific diagnostic criteria identify those at high risk for progression from ‘preaddiction’ to severe alcohol use disorder 93%
- Impact of year-long cannabis use for medical symptoms on brain activation during cognitive processes 90%
- Effectiveness of a Text Message Intervention Promoting Seat Belt Use Among Targeted Young Adults: A Randomized Clinical Trial 89%
Similar papers in this journal
- Epigenome-wide Association Study of Psilocybin-Induced Methylome Changes in Alcohol Use Disorder 94%
- Altered association of plasmatic oxytocin with affective stress responses in alcohol use disorder 93%
- Cross-Species Evidence for Hippocampal CACNA1C as a Therapeutic Target for Alcohol Use Disorder 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.